# Protective Effects of Oral L-Arginine CI-AKI

> **NCT02455960** · PHASE4 · UNKNOWN · sponsor: **Phramongkutklao College of Medicine and Hospital** · enrollment: 112 (estimated)

## Conditions studied

- Contrast Induced AKI

## Interventions

- **DIETARY_SUPPLEMENT:** L-arginine
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT02455960
- **Lead sponsor:** Phramongkutklao College of Medicine and Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-09
- **Primary completion:** 2016-04
- **Final completion:** 2016-05
- **Target enrollment:** 112 (ESTIMATED)
- **Last updated:** 2015-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02455960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02455960, "Protective Effects of Oral L-Arginine CI-AKI". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02455960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*